These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 22437488

  • 21. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
    Alshahrani SM, Lu W, Park JB, Morott JT, Alsulays BB, Majumdar S, Langley N, Kolter K, Gryczke A, Repka MA.
    AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
    [Abstract] [Full Text] [Related]

  • 22. The manufacture and characterisation of hot-melt extruded enteric tablets.
    Andrews GP, Jones DS, Diak OA, McCoy CP, Watts AB, McGinity JW.
    Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
    [Abstract] [Full Text] [Related]

  • 23. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.
    Sahoo J, Murthy PN, Biswal S, Manik.
    AAPS PharmSciTech; 2009 May; 10(1):27-33. PubMed ID: 19145487
    [Abstract] [Full Text] [Related]

  • 24. Application of film-casting technique to investigate drug-polymer miscibility in solid dispersion and hot-melt extrudate.
    Parikh T, Gupta SS, Meena AK, Vitez I, Mahajan N, Serajuddin AT.
    J Pharm Sci; 2015 Jul; 104(7):2142-52. PubMed ID: 25917333
    [Abstract] [Full Text] [Related]

  • 25. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion.
    Albers J, Alles R, Matthée K, Knop K, Nahrup JS, Kleinebudde P.
    Eur J Pharm Biopharm; 2009 Feb; 71(2):387-94. PubMed ID: 18951978
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Enhanced in vivo absorption of CB-1 antagonist in rats via solid solutions prepared by hot-melt extrusion.
    Ranzani LS, Font J, Galimany F, Santanach A, Gomez-Gomar AM, Casadevall G, Gryczke A.
    Drug Dev Ind Pharm; 2011 Jun; 37(6):694-701. PubMed ID: 21226628
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. In situ amorphisation of indomethacin with Eudragit® E during dissolution.
    Priemel PA, Laitinen R, Grohganz H, Rades T, Strachan CJ.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1259-65. PubMed ID: 24056054
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing Parameters.
    Li S, Tian Y, Jones DS, Andrews GP.
    AAPS PharmSciTech; 2016 Feb; 17(1):200-13. PubMed ID: 26729536
    [Abstract] [Full Text] [Related]

  • 33. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
    Fule R, Dhamecha D, Maniruzzaman M, Khale A, Amin P.
    Int J Pharm; 2015 Dec 30; 496(1):137-56. PubMed ID: 26471056
    [Abstract] [Full Text] [Related]

  • 34. Structural modifications of polymethacrylates: impact on thermal behavior and release characteristics of glassy solid solutions.
    Claeys B, De Coen R, De Geest BG, de la Rosa VR, Hoogenboom R, Carleer R, Adriaensens P, Remon JP, Vervaet C.
    Eur J Pharm Biopharm; 2013 Nov 30; 85(3 Pt B):1206-14. PubMed ID: 23485474
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.
    Milne M, Liebenberg W, Aucamp M.
    AAPS PharmSciTech; 2015 Oct 30; 16(5):1190-202. PubMed ID: 25732372
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Melt extrusion vs. spray drying: The effect of processing methods on crystalline content of naproxen-povidone formulations.
    Haser A, Cao T, Lubach J, Listro T, Acquarulo L, Zhang F.
    Eur J Pharm Sci; 2017 May 01; 102():115-125. PubMed ID: 28259831
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.